To assess the role of drug resistance in these failures, investigators examined whether DHPS mutations are more frequent among patients with or without prior exposure to sulfa agents, and whether infections in patients with or without DHPS mutations are more likely to be unresponsive to a sulfa drug. The gene discussed is DHPS; the disease is infection.